Cargando…

EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells

BACKGROUND: BRAF inhibitor (BRAF-I) therapy for melanoma patients harboring the V600E mutation is initially highly effective, but almost all patients relapse within a few months. Understanding the molecular mechanisms behind BRAF-I responsiveness and acquired resistance is therefore an important iss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurenzana, Anna, Margheri, Francesca, Biagioni, Alessio, Chillà, Anastasia, Pimpinelli, Nicola, Ruzzolini, Jessica, Peppicelli, Silvia, Andreucci, Elena, Calorini, Lido, Serratì, Simona, Del Rosso, Mario, Fibbi, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355443/ https://www.ncbi.nlm.nih.gov/pubmed/30611716 http://dx.doi.org/10.1016/j.ebiom.2018.12.024

Ejemplares similares

uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells
por: Biagioni, Alessio, et al.
Publicado: (2020)

uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma Cells
por: Andreucci, Elena, et al.
Publicado: (2022)

CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines
por: Biagioni, Alessio, et al.
Publicado: (2021)

Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme
por: Laurenzana, Anna, et al.
Publicado: (2014)

uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines
por: Biagioni, Alessio, et al.
Publicado: (2020)

Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis
por: Margheri, Francesca, et al.
Publicado: (2015)

Anoikis Resistance as a Further Trait of Acidic-Adapted Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2019)

Type II CRISPR/Cas9 approach in the oncological therapy
por: Biagioni, A., et al.
Publicado: (2017)

The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style
por: Margheri, Francesca, et al.
Publicado: (2014)

miR-214-Enriched Extracellular Vesicles Released by Acid-Adapted Melanoma Cells Promote Inflammatory Macrophage-Dependent Tumor Trans-Endothelial Migration
por: Andreucci, Elena, et al.
Publicado: (2022)

The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
por: Andreucci, Elena, et al.
Publicado: (2018)

FDG uptake in cancer: a continuing debate
por: Peppicelli, Silvia, et al.
Publicado: (2020)

Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry
por: Andreucci, Elena, et al.
Publicado: (2022)

SOX2 as a novel contributor of oxidative metabolism in melanoma cells
por: Andreucci, Elena, et al.
Publicado: (2018)

Correction: Desmoglein-2-Integrin Beta-8 Interaction Regulates Actin Assembly in Endothelial Cells: Deregulation in Systemic Sclerosis
por: Giusti, Betti, et al.
Publicado: (2013)

GDF5 Regulates TGFß-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and In Vivo Control by Anti-TGFß Peptides
por: Margheri, Francesca, et al.
Publicado: (2012)

Desmoglein-2-Integrin Beta-8 Interaction Regulates Actin Assembly in Endothelial Cells: Deregulation in Systemic Sclerosis
por: Giusti, Betti, et al.
Publicado: (2013)

Mature and progenitor endothelial cells perform angiogenesis also under protease inhibition: the amoeboid angiogenesis
por: Chillà, Anastasia, et al.
Publicado: (2018)

Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
por: Biagioni, Alessio, et al.
Publicado: (2019)

Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2022)

Tumor-tropic endothelial colony forming cells (ECFCs) loaded with near-infrared sensitive Au nanoparticles: A “cellular stove” approach to the photoablation of melanoma
por: Margheri, Giancarlo, et al.
Publicado: (2016)

Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma
por: Chillà, Anastasia, et al.
Publicado: (2020)

A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer
por: Ruzzolini, Jessica, et al.
Publicado: (2019)

The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells
por: Peppicelli, Silvia, et al.
Publicado: (2020)

The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells
por: Andreucci, Elena, et al.
Publicado: (2020)

Delivery systems of CRISPR/Cas9-based cancer gene therapy
por: Biagioni, Alessio, et al.
Publicado: (2018)

u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression
por: Ciavarella, S, et al.
Publicado: (2017)

Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2019)

Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies
por: Ruzzolini, Jessica, et al.
Publicado: (2018)

An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy
por: Peri, Sara, et al.
Publicado: (2022)

Cancer Glycolytic Dependence as a New Target of Olive Leaf Extract
por: Ruzzolini, Jessica, et al.
Publicado: (2020)

Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer
por: Andreucci, Elena, et al.
Publicado: (2023)

Inflammatory cytokines induce vascular endothelial growth factor-C expression in melanoma-associated macrophages and stimulate melanoma lymph node metastasis
por: PEPPICELLI, SILVIA, et al.
Publicado: (2014)

Dynamic scenario of metabolic pathway adaptation in tumors and therapeutic approach
por: Peppicelli, Silvia, et al.
Publicado: (2015)

Oleuropein-Rich Leaf Extract as a Broad Inhibitor of Tumour and Macrophage iNOS in an Apc Mutant Rat Model
por: Ruzzolini, Jessica, et al.
Publicado: (2021)

Oleuropein, a Bioactive Compound from Olea europaea L., as a Potential Preventive and Therapeutic Agent in Non-Communicable Diseases
por: Nediani, Chiara, et al.
Publicado: (2019)

Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP‐Enriched Endothelial Colony Forming Cells on Melanoma
por: Armanetti, Paolo, et al.
Publicado: (2020)

Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells
por: Bianchini, Francesca, et al.
Publicado: (2016)

Inhibition of MMPs supports amoeboid angiogenesis hampering VEGF-targeted therapies via MLC and ERK 1/2 signaling
por: Chillà, Anastasia, et al.
Publicado: (2023)

Integrin is on uPAR to unleash cells
por: LeBrasseur, Nicole
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_vbfeperkinh97pm8lve72ackum